Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Cytokine cascade and networks among MSM HIV seroconverters: implications for early immunotherapy
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
Cytokine cascade and networks among MSM HIV seroconverters: implications for early immunotherapy
Creator
Liu, Lihong
Wang, Pengfei
Li, Zhen
Chen, Hui
Li, Ning
Wu, Hao
Su, Bin
Zhang, Tong
Li, Lan
Huang, Xiaojie
Li, Haiying
Liu, Xinchao
Meyers, Kathrine
topic
covid:adc882dda7e73073791ae83afee7affd0d3e3793#this
source
Medline; PMC
abstract
The timing, intensity and duration of the cytokine cascade and reorganized interrelations in cytokine networks are not fully understood during acute HIV-1 infection (AHI). Using sequential plasma samples collected over three years post-infection in a cohort of MSM HIV-1 seroconvertors, we determined the early kinetics of cytokine levels during FiebigI-IV stages using Luminex-based multiplex assays. Cytokines were quantified and relationships between cytokines were assessed by Spearman correlation. Compared with HIV-negative MSM, HIV-infected individuals had significantly increased multiple plasma cytokines, including GM-CSF, IFN-α2, IL-12p70, IP-10 and VEGF, during both acute and chronic stages of infection. Furthermore, rapid disease progressors (RDPs) had earlier and more robust cytokine storms, compared with slow disease progressors (SDPs) (49.6 days vs. 74.9 days, respectively; 6.7-fold vs. 3.7-fold change of cytokines, respectively), suggesting the faster and stronger cytokine storm during AHI could promote disease progression. On the other hand, HIV-1 infection induced more interlocked cytokines network, establishing new strong correlations and imposing a higher rigidity. There were, respectively, 146 (44.9%) statistically significant correlations of cytokines in RDPs and 241 (74.2%) in SDPs (p < 0.001). This study suggests that immunomodulatory interventions aimed at controlling cytokine storm in AHI may be beneficial to slow eventual disease progression.
has issue date
2016-11-10
(
xsd:dateTime
)
bibo:doi
10.1038/srep36234
bibo:pmid
27830756
has license
cc-by
sha1sum (hex)
adc882dda7e73073791ae83afee7affd0d3e3793
schema:url
https://doi.org/10.1038/srep36234
resource representing a document's title
Cytokine cascade and networks among MSM HIV seroconverters: implications for early immunotherapy
has PubMed Central identifier
PMC5103227
has PubMed identifier
27830756
schema:publication
Sci Rep
resource representing a document's body
covid:adc882dda7e73073791ae83afee7affd0d3e3793#body_text
is
http://vocab.deri.ie/void#inDataset
of
https://covidontheweb.inria.fr:4443/about/id/http/ns.inria.fr/covid19/adc882dda7e73073791ae83afee7affd0d3e3793
is
schema:about
of
named entity 'INCREASED'
named entity 'SUGGEST'
named entity 'INFECTED'
named entity 'AHI'
named entity 'GM-CSF'
named entity 'LIMITING'
named entity 'POST'
named entity 'DOUBLE'
named entity 'GROWING'
named entity 'ROLE'
named entity 'ACUTE HIV INFECTION'
named entity 'T CELL'
named entity 'DYNAMIC'
named entity 'KINETICS'
named entity 'USING'
named entity 'STATISTICALLY SIGNIFICANT'
named entity 'TIMING'
named entity 'DETERMINED'
named entity 'MSM'
named entity 'HIV-1'
named entity 'NATURAL'
named entity 'DURATION'
named entity 'BENEFICIAL'
named entity 'DIVERSITY'
named entity 'UNDERSTOOD'
named entity 'ANTIVIRAL'
named entity 'GENES'
named entity 'FIGHTING'
named entity 'PRODUCTION'
named entity 'POTENTIAL'
named entity 'NETWORKS'
named entity 'REPORTS'
named entity 'BASED'
named entity 'IFN'
named entity 'HAND'
named entity '28P'
named entity 'COMPARED'
named entity 'SPECIFIC IMMUNITY'
named entity 'TO PRODUCE'
named entity 'STUDIES'
named entity 'PROMOTE'
named entity 'CYTOKINE STORM'
named entity 'CYTOKINE LEVELS'
named entity 'VIRAL PERSISTENCE'
named entity 'STAGES'
named entity 'POINTS'
named entity 'ACUTE'
named entity 'ROBUST'
named entity 'INITIAL'
named entity 'PLASMA'
named entity 'CASCADE'
named entity 'MACROPHAGES'
named entity 'SLOW'
named entity 'THESE'
named entity 'cytokine'
named entity 'Some'
named entity 'chronic'
named entity 'HIV-1 infection'
named entity 'acute HIV infection'
named entity 'slow'
named entity 'production'
named entity 'strong'
named entity 'immune system'
named entity 'cytokines'
named entity 'progressors'
named entity 'unity'
named entity 'type'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 10
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software